Informações:
Falhas:
ID
12241
Descrição
An open-label, multicenter, randomized, comparative, phase III study to evaluate the efficacy and safety of rituximab plus fludarabine and cyclophosphamide (FCR) versus fludarabine and cyclophosphamide alone (FC) in previously treated patients with CD20 positive B-cell chronic lymphocytic leukemia (CLL). FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients NCT00090051 Roche BO17072
Palavras-chave
Versões (2)
- 30/09/2015 30/09/2015 -
- 28/10/2015 28/10/2015 -
Transferido a
28 de outubro de 2015
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
CLL Adverse Event BO17072 NCT00090051
Adverse event or intercurrent illness Chronic Lymphocytic Leukemia NCT00090051 BO17072
Similar models
Adverse event or intercurrent illness Chronic Lymphocytic Leukemia NCT00090051 BO17072
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Name adverse event
Item
Name adverse event
integer
C0877248 (UMLS CUI [1])
Adverse Event Onset Date
Item
Date of Onset
date
C2985916 (UMLS CUI [1])
Serious Adverse Event
Item
Serious Adverse Event
boolean
C1519255 (UMLS CUI [1])
Adverse Event
Item
Did this event start during a MabThera® infusion?
boolean
C1314901 (UMLS CUI [1])
Adverse event
Item
Did this event start within 24 hours of finishing a MabThera® infusion?
boolean
C0877248 (UMLS CUI [1])
CL Item
CTCAE grade 1 (1)
C1556202 (UMLS CUI-1)
CL Item
CTCAE grade 2 (2)
C1556203 (UMLS CUI-1)
CL Item
CTCAE grade 3 (3)
C1556204 (UMLS CUI-1)
CL Item
CTCAE grade 4 (4)
C1556205 (UMLS CUI-1)
CL Item
none (1)
C0549184 (UMLS CUI-1)
CL Item
dosage modified/interrupted (2)
C0392747 (UMLS CUI-1)
CL Item
discontinued (3)
C1444662 (UMLS CUI-1)
Adverse event treatment
Item
Was treatment given for this event
boolean
C2981656 (UMLS CUI [1])
Item
Most extreme intensity CTCAE grade
integer
C1517874 (UMLS CUI [1])
CL Item
CTCAE grade 1 (1)
C1556202 (UMLS CUI-1)
CL Item
CTCAE grade 2 (2)
C1556203 (UMLS CUI-1)
CL Item
CTCAE grade 3 (3)
C1556204 (UMLS CUI-1)
CL Item
CTCAE grade 4 (4)
C1556205 (UMLS CUI-1)
CL Item
unrelated (1)
C0445356 (UMLS CUI-1)
CL Item
remote (2)
C0205157 (UMLS CUI-1)
CL Item
possible (3)
C0332149 (UMLS CUI-1)
CL Item
probable (4)
C1709683 (UMLS CUI-1)
CL Item
resolved, no sequelae (1)
CL Item
resolved, with sequelae (2)
CL Item
unresoved (3)
CL Item
death (4)
Resolved Date
Item
Resolved Date
date
C0011008 (UMLS CUI [1])
Adverse Event Comment
Item
Adverse Event Comment
text
C0947611 (UMLS CUI [1])
Name of treatment
Item
Name of treatment
integer
C2826274 (UMLS CUI [1])
Treatment Start Date
Item
Treatment Start Date
date
C3173309 (UMLS CUI [1])
Treatment End Date
Item
Treatment End Date
date
C1531784 (UMLS CUI [1])
Treatment Ongoing
Item
Treatment Ongoing
boolean
C2091305 (UMLS CUI [1])